Sanai Health Industry Group Company Limited (HKG:1889)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Products	85.90M	85.05M	100.52M	152.65M	53.82M
Pharmaceutical Products Growth	1.00%	-15.39%	-34.15%	183.66%	19.68%
Finance Leasing	-	170.00K	7.25M	14.82M	9.30M
Finance Leasing Growth	-	-97.65%	-51.09%	59.33%	40.82%
Genetic Testing and Molecular Diagnostic Services	-	-	-	8.45M	4.49M
Genetic Testing and Molecular Diagnostic Services Growth	-	-	-	88.11%	-23.02%
Total	85.90M	85.22M	107.77M	175.92M	67.61M
Total Growth	0.80%	-20.92%	-38.74%	160.21%	-44.31%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Peoples Republic of China (PRC)	85.90M	85.22M	107.77M	167.47M	63.12M
Peoples Republic of China (PRC) Growth	0.80%	-20.92%	-35.65%	165.34%	2.78%
Hong Kong	-	-	-	8.45M	4.49M
Hong Kong Growth	-	-	-	88.11%	-23.06%
Total	85.90M	85.22M	107.77M	175.92M	67.61M
Total Growth	0.80%	-20.92%	-38.74%	160.21%	-44.31%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 17, 2026

Data Sources Report a data error